Dianthus TherapeuticsDNTH
那斯達克 · USD
89.30
+0.49
(+0.55%)
收盤 11/12 04:59 (UTC+8)
盤後
88.00
88.00
(-1.46%)
11/12 04:59 (UTC+8)
Dianthus TherapeuticsDNTH
89.30
+0.49
(+0.55%)
財務數據
損益表
- 0.02
- 0.02
- 0.01
- 0.01
- 0.00
- 0.00
- 0.00
- 0.00
- 0.01
- 0.01
- 113.16
- 16.59
- -38.95
- -12.29
- -83.40
- 105.18
- -28.28
- 63.03
- 64.36
- 59.00
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q3 | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | |
營業收入淨額 | 1,210 | 761 | 463 | 284 | 396 | 193 | 1,163 | 1,326 | 2,172 | 1,863 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,210 | 761 | 463 | 284 | 396 | 193 | 1,163 | 1,326 | 2,172 | 1,863 |
營業費用 | 59,682 | 62,243 | 46,996 | 69,825 | 40,684 | 35,120 | - | - | - | - |
研發費用 | 45,600 | 48,686 | 34,528 | 59,895 | 32,489 | 26,251 | 27,003 | 26,413 | 25,544 | 18,070 |
推銷及管理費用 | 14,082 | 13,557 | 12,468 | 9,930 | 8,195 | 8,869 | 7,337 | 6,829 | 6,528 | 5,997 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -58,472 | -61,482 | -46,533 | -69,541 | -40,288 | -34,927 | -33,177 | -31,916 | -29,900 | -22,204 |
其他收入及費用 | 11,829 | 11,267 | 5,699 | 5,109 | 3,523 | 3,298 | 3,666 | 3,476 | 4,726 | 4,597 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -46,643 | -50,215 | -40,834 | -64,432 | -36,765 | -31,629 | -29,511 | -28,440 | -25,174 | -17,607 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -46,643 | -50,215 | -40,834 | -64,432 | -36,765 | -31,629 | -29,511 | -28,440 | -25,174 | -17,607 |
基本每股稅後盈餘(元) | -0.81 | -0.90 | -0.85 | -1.43 | -0.97 | -0.88 | -0.82 | -0.81 | -0.74 | -0.51 |
稀釋每股稅後盈餘(元) | -0.81 | -0.90 | -0.85 | -1.52 | -0.97 | -0.89 | -0.82 | -0.82 | -0.74 | -0.45 |
基本平均股數(千股) | 57341.00 | 56029.00 | 48032.00 | 44971.00 | 37794.00 | 35822.00 | 35790.00 | 35033.00 | 34236.00 | 34227.00 |
稀釋平均股數(千股) | 57341.00 | 56029.00 | 48032.00 | 44971.00 | 37794.00 | 35822.00 | 35790.00 | 35033.00 | 34236.00 | 34227.00 |
還原基本每股稅後盈餘(元) | -0.81 | -0.90 | -0.85 | -1.43 | -0.97 | -0.88 | -0.82 | -0.81 | -0.74 | -0.51 |
還原稀釋每股稅後盈餘(元) | -0.81 | -0.90 | -0.85 | -1.52 | -0.97 | -0.89 | -0.82 | -0.82 | -0.74 | -0.45 |
還原基本平均股數(千股) | 57,341 | 56,029 | 48,032 | 44,971 | 37,794 | 35,822 | 35,790 | 35,033 | 34,236 | 34,227 |
還原稀釋平均股數(千股) | 57,341 | 56,029 | 48,032 | 44,971 | 37,794 | 35,822 | 35,790 | 35,033 | 34,236 | 34,227 |
EBITDA(千元) | -47,415 | -55,762 | -41,976 | -65,190 | -38,977 | -32,628 | -31,277 | -31,099 | -27,399 | -17,918 |